TSX/ABBV (TSX/ABBV)

Toronto Stock Exchange: TSX/ABBV · CAD

CA$39.8

+0.09 (+0.2%)· Recorded snapshot

Market cap	712.4B
Revenue (ttm)	91.4B
Net income (ttm)	8.9B
EPS (ttm)	CA$0.49
P/E (trailing)	81.1x
P/E (forward)	19.1x
Dividend	CA$1.20 (3.02%)
Volume	550

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 91.4B
Net income (ttm): 8.9B
EPS (ttm): CA$0.49
P/E (trailing): 81.1x
P/E (forward): 19.1x
Market cap: 712.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.1

P25 n/aP50 n/aP75 n/a

Trailing P/E81.1

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC17.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/ABBV indicators

Market & fundamental data

Available fields

234

Groups with data

Currency

USD

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	United States
Country code	CA
Earnings date	2026-10-30
Employees	57,000
Employees change	5,000
Employees growth	10%
Enterprise value	CAD 802.8B
Exchange	Toronto Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2012
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	CA00288K1084
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Market cap	CAD 712.4B
Next earnings date	2026-10-30
Price	CAD 39.75
Price currency	CAD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	tsx/ABBV
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	41.3x
Average P/E ratio (3Y)	81.44x
Average P/E ratio (5Y)	58.76x
Earnings yield	1.23%
EV/Earnings	89.98x
EV/EBIT	24.92x
EV/EBITDA	18.31x
EV/FCF	30.98x
EV/Sales	8.86x
FCF / EV yield	3.23%
FCF yield	3.64%
Forward P/E	19.06x
Lynch fair value	CAD 2.48
Lynch upside	-93.74%
P/(FCF - SBC) ratio	29.04x
P/(OCF - SBC) ratio	27.01x
P/E ratio	81.09x
P/FCF ratio	27.49x
P/OCF ratio	25.66x
P/S ratio	7.77x
Price/EBITDA ratio	16.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	35.56%
EBITDA margin	47.78%
Effective tax rate	27.39%
FCF margin	28.57%
Gross margin	72.79%
Operating margin	35.56%
Pretax margin	13.51%
Profit margin	9.8%
Profit per employee	CAD 156,211
Profitable quarters	6
Profitable years	17
Revenue per employee	CAD 1.6M
ROA	10.51%
ROA (5Y)	8.68%
ROCE	24.49%
ROE (5Y)	1,295.17%
ROIC	17.7%
ROIC (5Y)	21.99%
SBC / revenue	1.52%
Tax / revenue	3.7%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	68.54%
EPS growth (Q)	290.39%
EPS growth (QoQ)	422.72%
EPS growth 10Y	0.21%
EPS growth 3Y	-10.05%
EPS growth 5Y	-0.92%
EPS growth quarters	1
EPS growth years	0
FCF growth	-0.16%
FCF growth (Q)	-36.24%
FCF growth (QoQ)	-12.63%
FCF growth 3Y	-9.78%
FCF growth 5Y	-1.43%
Gross profit growth	12.78%
Gross profit growth (Q)	14.64%
Gross profit growth 3Y	5.88%
Gross profit growth 5Y	5.07%
Net income growth	67.69%
Net income growth (Q)	285.18%
Net income growth (QoQ)	424.16%
Net income growth 3Y	-10.12%
Net income growth 5Y	-1.02%
Net income growth quarters	1
Net income growth years	0
OCF growth	1.16%
OCF growth (Q)	-33.32%
OCF growth (QoQ)	-10.26%
OCF growth 10Y	9.1%
OCF growth 3Y	-8.59%
OCF growth 5Y	-0.94%
Operating income growth	21.17%
Operating income growth (Q)	17.54%
Operating income growth 3Y	3.56%
Operating income growth 5Y	3.75%
Revenue growth	10.39%
Revenue growth (Q)	10.16%
Revenue growth (QoQ)	13.25%
Revenue growth 10Y	10.03%
Revenue growth 3Y	4.75%
Revenue growth 5Y	3.69%
Revenue growth quarters	10
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -1.8B
Depreciation and amortization	CAD 11.1B
EBIT	CAD 32.5B
EBITDA	CAD 43.7B
EPS	CAD 0.49
Financing cash flow	CAD -18.3B
Free cash flow	CAD 25.9B
Free cash flow minus SBC	CAD 24.5B
Gross profit	CAD 66.6B
Income taxes	CAD 3.4B
Investing cash flow	CAD -9.2B
Net borrowing	CAD 587.7M
Net cash flow	CAD 144.9M
Net income	CAD 8.9B
Operating cash flow minus SBC	CAD 26.3B
Operating income	CAD 32.5B
Revenue	CAD 91.4B
Stock-based compensation	CAD 1.4B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.42
Book value per share	CAD -4.77
Debt / EBITDA	2.28
Debt / FCF	3.89
Goodwill	CAD 49.9B
Interest coverage	7.85
Long-term assets	CAD 144.5B
Long-term liabilities	CAD 141.7B
Net cash (debt)	CAD -91.3B
Net cash / market cap	-12.85%
Net debt / EBITDA	2.09
Net debt / FCF	3.53
Piotroski F-Score	8
Property, plant and equipment	CAD 8.1B
Shareholders' equity	CAD -8.4B
Tangible book value	CAD -128.7B
Tangible book value per share	CAD -72.80
Total assets	CAD 191.9B
Total cash	CAD 9.3B
Total debt	CAD 100.7B
Total liabilities	CAD 200.2B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.47
Current assets	CAD 47.3B
Current liabilities	CAD 58.5B
Current ratio	0.81
Inventory turnover	3.47
Net working capital	CAD -8.8B
Quick ratio	0.49
Working capital	CAD -11.3B
Working capital turnover	-9.9

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.03%
Dividend growth	28.19%
Dividend growth years	1
Dividend payment date	2026-11-23
Dividend payment years	3
Dividend payout frequency	Quarterly
Dividend per share	CAD 1.20
Dividend yield	3.02%
Ex-dividend date	2026-10-15
Last dividend	CAD 0.24
Payout ratio	189.83%
Shareholder yield	3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 33.56
1D price change	0.23%
1M price change	8.22%
1M total return	8.88%
1W price change	-1.12%
1W total return	-1.12%
1Y price change	23.1%
1Y return CAGR	27.79%
1Y total return	27.77%
20-day SMA	CAD 38.53
200-day SMA	CAD 32.99
3M price change	10.82%
3M total return	11.49%
3Y price change	95.72%
3Y return CAGR	29.23%
3Y total return	115.84%
50-day SMA	CAD 37.20
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 40.26
52-week high date	2026-10-15
52-week low	CAD 26.89
52-week low date	2026-04-29
6M price change	43.97%
6M total return	45.87%
All-time high	CAD 40.26
All-time high date	2026-10-15
All-time low	CAD 19.45
All-time low date	2023-06-28
Average true range (ATR)	CAD 0.51
Average volume	5.1K
Change from 52-week high	-1.27%
Change from 52-week low	47.82%
Change from all-time high	-1.27%
Change from all-time low	104.37%
Change from open	0%
Day's gap	0.23%
Dollar volume	CAD 21,863
High price	CAD 39.79
Low price	CAD 39.75
Monthly RSI	72.27
Open price	CAD 39.75
Position in 52-week range	0%
Previous close	CAD 39.66
Price vs 150-day SMA	18.44%
Price vs 20-day SMA	3.16%
Price vs 200-day SMA	20.49%
Price vs 50-day SMA	6.86%
Relative volume	0.11
RSI	66.62
Sharpe ratio	0.89
Sharpe ratio (3Y)	0.89
Sortino ratio	1.56
Sortino ratio (3Y)	1.47
Volume	550
Weekly RSI	69.29
YTD price change	22.69%
YTD total return	27.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.8B
Shares change (QoQ)	-0.23%
Shares change (YoY)	0.03%
Shares held by insiders	0.07%
Shares held by institutions	76.58%
Short ratio	3.2 days

Deeper analysis on TSX/ABBV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/ABBV report

Is a complete TSX/ABBV research report available?

No complete published report is available for tsx/ABBV (TSX/ABBV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/ABBV (TSX/ABBV)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/ABBV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/ABBV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/ABBV

Frequently asked questions